Slade Health | Scoop InfoPages scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
AUCKLAND, New Zealand, May 28, 2021 - Slade Health, part of the Icon Group network, today announced it has entered into a long-term agreement with the Auckland District Health Board (ADHB) to provide sterile compounding services to meet the growing needs .
Press Release – Slade Health
AUCKLAND, New Zealand, May 28, 2021 – Slade Health, part of the Icon Group network, today announced it has entered into a long-term agreement with the Auckland District Health Board (ADHB) to provide sterile compounding services to meet the growing needs of cancer patients in the region.This agreement will see Slade design, build and operate a world-class, GMP (Medsafe) licensed sterile compounding facility delivering chemotherapy, antibiotics, analgesics and nutritional infusions for public and private hospitals across New Zealand.
Slade Health is Australia’s largest sterile chemotherapy compounder with a strong 50-year history in the pharmaceutical industry.
The partnership marks a transition for ADHB from compounding chemotherapy and other sterile products in a pharmacy-based environment to a highly-regulated manufacturing environment. Slade’s expertise in manufacturing customised patient specific infusions will save time, reduce wastage and
Press Release – Slade Health AUCKLAND, New Zealand, May 28, 2021 – Slade Health, part of the Icon Group network, today announced it has entered into a long-term agreement with the Auckland District Health Board (ADHB) to provide sterile compounding services to meet the growing needs …
AUCKLAND, New Zealand, May 28, 2021 – Slade Health, part of the Icon Group network, today announced it has entered into a long-term agreement with the Auckland District Health Board (ADHB) to provide sterile compounding services to meet the growing needs of cancer patients in the region. This agreement will see Slade design, build and operate a world-class, GMP (Medsafe) licensed sterile compounding facility delivering chemotherapy, antibiotics, analgesics and nutritional infusions for public and private hospitals across New Zealand.